Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (1600)	3/31/1998 1:19:00 PM
From: Patrick Serafino	Read Replies (2) \| Respond to of 1894

Frank; I am glad to hear that the press conference was positive. I am planning to stay the course for right now. Was there any mention of when they are expecting to make a profit. I assume from the numbers that were released today that third quarter of this year is unrealistic. BTW my entry point was 3 1/2 my dollar cost average is 2 1/8. One thing that I find curious is still the narrow trading range, it seems that reaction to both good and bad news at this point is very muted. What do you make of that?

To: Frank Buck who wrote (1600)	3/31/1998 4:40:00 PM
From: ariz23	Read Replies (1) \| Respond to of 1894

Amazing - my pathologist felt the seminar in Chicago was poorly attended. 60 at most. Many of which were not serious about the product. He also learned there is a lab in Chicago that asked for monies to be returned when they decided to not go with the ACCELL. They are still waiting for the money to be returned ( about a year now). As for documented gains...... Just one lab.... Detroit seems to have seen it. All other data that has been given to the public is in house and how reliable is that ? After what I learned from my pathologist who attended the meeting and checking this board and the stock price history, looks like I will not be investing.